Publications

Emerging evidence on heterologous COVID-19 vaccine schedules-To mix or not to mix?.

PARKER, EP K; Desai, S; Marti, M; O'Brien, KL; Kaslow, DC; Kochhar, S; Olayinka, F; Cravioto, A; Nohynek, H; Hombach, J; Wilder-Smith, A;

2022

The Lancet Infectious Diseases, (2022).22 4 10.1016/S1473-3099(22)00178-5.

Global and regional burden of attributable and associated bacterial antimicrobial resistance avertable by vaccination: modelling study.

Kim, C; Holm, M; Frost, I; Hasso-Agopsowicz, M; Abbas, K;

2022

medRxiv (2022). 10.1101/2022.05.08.22274821.

COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery.

Toor, J; Li, X; JIT, M; Trotter, CL; Echeverria-Londono, S; Hartner, A-M; Roth, J; Portnoy, A; ABBAS, K; Ferguson, NM; Am Gaythorpe, K;

2022

Vaccine, (2022).40 31 10.1016/j.vaccine.2022.05.074.

WHO-led consensus statement on vaccine delivery costing: process, methods, and findings.

Levin, A; Boonstoppel, L; Brenzel, L; Griffiths, U; Hutubessy, R; JIT, M; Mogasale, V; Pallas, S; Resch, S; Suharlim, C; Yeung, KH T;

2022

BMC MEDICINE, (2022).20 1 10.1186/s12916-022-02278-4.

Improving Estimates of Social Contact Patterns for Airborne Transmission of Respiratory Pathogens.

MCCREESH, N; Mohlamonyane, M; Edwards, A; Olivier, S; Dikgale, K; Dayi, N; Gareta, D; Wood, R; GRANT, AD; WHITE, RG; Middelkoop, K;

2022

Emerging infectious diseases, (2022).28 10 10.3201/eid2810.212567.

Waning effectiveness of BNT162b2 and ChAdOx1 COVID-19 vaccines over six months since second dose: a cohort study using linked electronic health records.

Horne, EM F; Hulme, W; KEOGH, R; Palmer, T; WILLIAMSON, E; PARKER, EP K; Green, A; Walker, V; Walker, A; Curtis, H; Fisher, L; MacKenna, B; Croker, R; Hopcroft, L; Park, R; Massey, J; Morley, J; Mehrkar, A; Bacon, S; Evans, D; Inglesby, P; Morton, C; Hickman, G; Davy, S; Ward, T; ... Sterne, JA C.

2022

medRxiv (2022). 10.1101/2022.03.23.22272804.

Assessing the impacts of timing on the health benefits, cost-effectiveness and relative affordability of COVID-19 vaccination programmes in 27 African Countries.

LIU, Y; PEARSON, CA B; Madriz Montero, A; TORRES-RUEDA, S; Asfaw, E; Uzochukwu, B; Drake, T; Bergren, E; EGGO, R; RUIZ, F; Ndembi, N; Nonvignon, J; JIT, M; VASSALL, A;

2022

medRxiv (2022). 10.1101/2022.05.09.22274846.

Vaccine equity in low and middle income countries: a systematic review and meta-analysis.

Ali, HA; Hartner, A-M; Echeverria-Londono, S; Roth, J; Li, X; ABBAS, K; Portnoy, A; VYNNYCKY, E; Woodruff, K; Ferguson, NM; Toor, J; Gaythorpe, KA;

2022

International Journal for Equity in Health, (2022).21 1 10.1186/s12939-022-01678-5.

"We don't have the same bodies; we don't react the same way": mothers and adolescent girls' perceptions of the risks and benefits of HPV vaccination in France.

KARAFILLAKIS, E; Peretti-Watel, P; Verger, P; CHANTLER, T; LARSON, HJ;

2022

HUMAN VACCINES & IMMUNOTHERAPEUTICS, (2022).18 1 10.1080/21645515.2022.2036555.

Importance of ventilation and occupancy to Mycobacterium tuberculosis transmission rates in congregate settings.

Deol, AK; Shaikh, N; Middelkoop, K; Mohlamonyane, M; WHITE, RG; MCCREESH, N;